Michael G. Wood, is a biotech C-level executive and entrepreneur with a proven track record of supporting company formation and transforming them into the next stages of their growth. He has cofounded and served 4 years as COO and CFO for OncoMyx therapeutics, a venture-backed oncolytic immunotherapy (cancer) Platform and therapeutics biotech. Prior to OncoMyx, he helped launch & served as Vice President of Corporate Development & Operations at Crinetics Pharmaceuticals (NASDAQ: CRNX), a specialty endocrine therapeutics biotech. He has reported directly to CEO’s and interacted with BoD members consistently over the last 11 years. Has trained at 3 Fortune 100 companies in investment banking, management consulting and large pharma.